Antibiotic Resistance Market Size & Outlook, 2026-2034

Antibiotic Resistance Market Size, Share & Trends Analysis Report By Disease (cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute bacterial skin and skin structure infections), HABP (Hospital-acquired bacterial pneumonia), CABP (Community-acquired pneumonia), cIAI (Complicated intra-abdominal infection), BSI (Bloodstream infection)), By Pathogen (coli, pneumoniae, aeruginosa, aureus, baumannii, influenzae, difficile, faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034